Search results
Author(s):
Marco Valgimigli
,
Vijay Kunadian
,
Pascal Vranckx
,
et al
Start date:
Feb 22, 2023
View more
Author(s):
Marco Valgimigli
,
Eliano Navarese
,
Pascal Vranckx
Added:
1 year ago
This three-part programme delves into the critical importance of individualised antithrombotic treatment in both Acute Coronary Syndrome (ACS) and Chronic Coronary Syndrome (CCS).
Part one of this programme presents two compelling patient case studies.Prof Pascal Vranckx (Hartcentrum Hasselt, BE) presents a complex 62-year old male with stable angina and HFrEF, undergoing an elective…
View more
Author(s):
Christopher P Cannon
Added:
6 years ago
This interview with Christopher P. Cannon from Brigham and Women's Hospital, Boston, US discusses Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation (REDUAL-PCI).
Filmed by Radcliffe Cardiology on-site at ESC 2017.
View more
Patient Case Study
Video Series
Patient Case Study
Video Series
Author(s):
Darshni Arishta Jhagroe
,
Jur ten Berg
Added:
3 years ago
Dual antiplatelet therapy (DAPT) is indicated in patients who need to undergo percutaneous coronary intervention (PCI) procedures.1 Compared with oral anticoagulation (OAC) and aspirin, DAPT has been shown to reduce the risk of thrombotic events and the rate of bleeding events.2 Chronic OAC is required in up to 10 % of the patients undergoing PCI, and is usually indicated for AF and mechanical…
View more
Author(s):
Antonio Greco
,
Claudio Laudani
,
Carla Rochira
,
et al
Added:
1 year ago
Author(s):
Gabriele Pesarini
,
Sara Ariotti
,
Flavio Ribichini
Added:
3 years ago
Haemostasis is a complex phenomenon defined as the chain of mechanisms able to maintain the integrity of a closed, high-pressure circulatory system after vascular damage.1 Thrombogenesis represents the main process assuring haemostasis at each level of the vascular system, and its accurate regulation guarantees the correct balance between blood flow and damage repair. An uncontrolled thrombin…
View more
Author(s):
Andrew Archbold
Added:
3 years ago
Patients who undergo coronary artery stenting require dual antiplatelet therapy (DAPT) in order to reduce their risk of stent thrombosis. Long-term oral anticoagulation (OAC) is indicated for the primary and secondary prevention of thrombotic events in patients with atrial fibrillation (AF), mechanical heart valves, intra-cardiac thrombus, venous thromboembolic disease and some hypercoagulable…
View more
Anticoagulation after TAVI
Author(s):
Antonio Greco
,
Davide Capodanno
Added:
3 years ago
Article